Suppr超能文献

福莫特罗的药理学:一种创新的支气管扩张剂。

Pharmacology of formoterol: an innovative bronchodilator.

作者信息

Anderson G P

机构信息

Pharmaceuticals Division, CIBA-GEIGY AG, Basel, Switzerland.

出版信息

Agents Actions Suppl. 1991;34:97-115.

PMID:1686531
Abstract

Formoterol is an innovative, highly potent, beta-2 selective adrenoceptor agonist combining the clinical advantages of rapid onset of action with a duration of action in excess of 12 h. In vitro, formoterol is a potent airway smooth muscle relaxant with high intrinsic activity. Formoterol appears to be retained in airway smooth muscle for extended periods since its relaxant effect on human airway smooth muscle is resistant to repeated washing and formoterol displays "reassertion" of relaxation after washout of a beta-adrenoceptor antagonist. In addition to airway smooth muscle relaxation, formoterol inhibits a range of acute inflammatory processes in animal models including eosinophil activation and infiltration of the airways, microvascular leakage, and antigen-induced mediator release from human lung. Whether these non-airway smooth muscle effects may influence chronic airway inflammation in clinical asthma remains to be determined.

摘要

福莫特罗是一种创新的、高效能的β₂ 选择性肾上腺素能受体激动剂,它结合了起效迅速和作用持续时间超过12小时的临床优势。在体外,福莫特罗是一种具有高内在活性的强效气道平滑肌松弛剂。福莫特罗似乎能长时间滞留在气道平滑肌中,因为它对人气道平滑肌的松弛作用在反复冲洗后仍能持续,并且在β肾上腺素能受体拮抗剂洗脱后,福莫特罗会再次表现出松弛作用。除了气道平滑肌松弛作用外,福莫特罗在动物模型中还能抑制一系列急性炎症过程,包括嗜酸性粒细胞活化和气道浸润、微血管渗漏以及抗原诱导的人肺介质释放。这些非气道平滑肌效应是否会影响临床哮喘中的慢性气道炎症仍有待确定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验